This paper briefly presents the known data on the immune response to SARS-CoV-2, and also analyzes the possibilities and limitations of serological testing for antibodies that should be accounted for when planning population studies and interpreting their results
Immunity to COVID-19 and issues of screening for SARS-COV-2 antibodies